Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies

Abstract Phosphodiesterase (PDE) inhibitors, such as pentoxifylline (PTX), are used as pharmacological agents to enhance sperm motility in assisted reproductive technology (ART), mainly to aid the selection of viable sperm in asthenozoospermic ejaculates and testicular spermatozoa, prior to intracyt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mutyala Satish, Sandhya Kumari, Waghela Deeksha, Suman Abhishek, Kulhar Nitin, Satish Kumar Adiga, Padmaraj Hegde, Jagadeesh Prasad Dasappa, Guruprasad Kalthur, Eerappa Rajakumara
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6b92d4ccba4c4906872030c4e4ff86cb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b92d4ccba4c4906872030c4e4ff86cb
record_format dspace
spelling oai:doaj.org-article:6b92d4ccba4c4906872030c4e4ff86cb2021-12-02T17:47:03ZStructure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies10.1038/s41598-021-91636-y2045-2322https://doaj.org/article/6b92d4ccba4c4906872030c4e4ff86cb2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91636-yhttps://doaj.org/toc/2045-2322Abstract Phosphodiesterase (PDE) inhibitors, such as pentoxifylline (PTX), are used as pharmacological agents to enhance sperm motility in assisted reproductive technology (ART), mainly to aid the selection of viable sperm in asthenozoospermic ejaculates and testicular spermatozoa, prior to intracytoplasmic sperm injection (ICSI). However, PTX is reported to induce premature acrosome reaction (AR) and, exert toxic effects on oocyte function and early embryo development. Additionally, in vitro binding studies as well as computational binding free energy (ΔGbind) suggest that PTX exhibits weak binding to sperm PDEs, indicating room for improvement. Aiming to reduce the adverse effects and to enhance the sperm motility, we designed and studied PTX analogues. Using structure-guided in silico approach and by considering the physico-chemical properties of the binding pocket of the PDEs, designed analogues of PTX. In silico assessments indicated that PTX analogues bind more tightly to PDEs and form stable complexes. Particularly, ex vivo evaluation of sperm treated with one of the PTX analogues (PTXm-1), showed comparable beneficial effect at much lower concentration—slower AR, higher DNA integrity and extended longevity of  spermatozoa and  superior embryo quality. PTXm-1 is proposed to be a better pharmacological agent for ART than PTX for sperm function enhancement.Mutyala SatishSandhya KumariWaghela DeekshaSuman AbhishekKulhar NitinSatish Kumar AdigaPadmaraj HegdeJagadeesh Prasad DasappaGuruprasad KalthurEerappa RajakumaraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mutyala Satish
Sandhya Kumari
Waghela Deeksha
Suman Abhishek
Kulhar Nitin
Satish Kumar Adiga
Padmaraj Hegde
Jagadeesh Prasad Dasappa
Guruprasad Kalthur
Eerappa Rajakumara
Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
description Abstract Phosphodiesterase (PDE) inhibitors, such as pentoxifylline (PTX), are used as pharmacological agents to enhance sperm motility in assisted reproductive technology (ART), mainly to aid the selection of viable sperm in asthenozoospermic ejaculates and testicular spermatozoa, prior to intracytoplasmic sperm injection (ICSI). However, PTX is reported to induce premature acrosome reaction (AR) and, exert toxic effects on oocyte function and early embryo development. Additionally, in vitro binding studies as well as computational binding free energy (ΔGbind) suggest that PTX exhibits weak binding to sperm PDEs, indicating room for improvement. Aiming to reduce the adverse effects and to enhance the sperm motility, we designed and studied PTX analogues. Using structure-guided in silico approach and by considering the physico-chemical properties of the binding pocket of the PDEs, designed analogues of PTX. In silico assessments indicated that PTX analogues bind more tightly to PDEs and form stable complexes. Particularly, ex vivo evaluation of sperm treated with one of the PTX analogues (PTXm-1), showed comparable beneficial effect at much lower concentration—slower AR, higher DNA integrity and extended longevity of  spermatozoa and  superior embryo quality. PTXm-1 is proposed to be a better pharmacological agent for ART than PTX for sperm function enhancement.
format article
author Mutyala Satish
Sandhya Kumari
Waghela Deeksha
Suman Abhishek
Kulhar Nitin
Satish Kumar Adiga
Padmaraj Hegde
Jagadeesh Prasad Dasappa
Guruprasad Kalthur
Eerappa Rajakumara
author_facet Mutyala Satish
Sandhya Kumari
Waghela Deeksha
Suman Abhishek
Kulhar Nitin
Satish Kumar Adiga
Padmaraj Hegde
Jagadeesh Prasad Dasappa
Guruprasad Kalthur
Eerappa Rajakumara
author_sort Mutyala Satish
title Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
title_short Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
title_full Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
title_fullStr Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
title_full_unstemmed Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
title_sort structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6b92d4ccba4c4906872030c4e4ff86cb
work_keys_str_mv AT mutyalasatish structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT sandhyakumari structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT wagheladeeksha structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT sumanabhishek structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT kulharnitin structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT satishkumaradiga structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT padmarajhegde structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT jagadeeshprasaddasappa structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT guruprasadkalthur structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
AT eerapparajakumara structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies
_version_ 1718379534078705664